Featured Research

from universities, journals, and other organizations

Discovery Of Widespread Tumor Growth Gene Holds Promise For Effective Anti-cancer Treatment

Date:
September 25, 2007
Source:
European Cancer Conference
Summary:
Scientists have found a widespread mechanism for the stimulation of tumor growth in humans, and that this is leading to the development of novel diagnostic and therapeutic procedures. This research may be key to the identification of signalling molecules that promote or inhibit the formation of metastases.

Italian scientists announced on September 24 that they have found a new and promising target for anti-tumour therapy in cancer.

Related Articles


Professor Saverio Alberti, from the CESI, University of Chieti Foundation, Chieti, told the European Cancer Conference that he and his team have found a widespread mechanism for the stimulation of tumour growth in humans, and that this is leading to the development of novel diagnostic and therapeutic procedures.

Professor Alberti and his team have discovered the function of the Trop-2 gene, a product of the TACTD2 gene, which is expressed in placenta, an 'invasive' normal tissue. "The function of Trop-2 was a mystery until now," says Professor Alberti, "but knowing its expression in the trophoblast (cells forming the outer layer of the blastocyst -- the stage between the fertilised egg and the embryo) during pregnancy, we thought that it might well be involved in another invasive function -- tumour growth."

The scientists analysed the genes in human tumours and found that Trop-2 was expressed in the vast majority of human cancers, for example, breast, colon, stomach, lung, prostate, ovary, endometrium, uterine cervix and pancreas. Over-expression of the Trop-2 gene was also found when immunohistochemical (IHC) analysis of 1,755 tumours was undertaken.

IHC analysis looks at the interaction of antibodies and antigens in tissues, and has the advantage of showing exactly where in a tissue a given protein is located. "This has allowed us to develop anti-Trop-2 monoclonal antibodies for immunotherapy (modulation of the immune system to reject and destroy tumours) of Trop-2 expressing tumours," explains Professor Alberti.

Trop-2 over-expression was found in between 65% and 90% of the tumour types analysed, with an average of 74% across the board. "These figures are high," explains Professor Alberti. "In comparison, telomerase over-expression, possibly the most fundamental mechanism for cell immortalisation, is observed in 80% of all tumours.

Telomerase is an enzyme that adds specific DNA repeats to the ends of chromosomes, so not strictly comparable. When we come to look at genes, her2/neu is a key determinant of breast cancer aggressiveness and is over-expressed in 25% of the cancers, and amplified in only a subgroup of them; and p53, possibly the most fundamental of tumour suppressors, is mutated and/or over-expressed in 50% of tumours.

Mutations of the epidermal growth factor receptor gene (EGFR) are relatively infrequent in most cancers, reach 30% of the non small-cell lung cancers and are present at frequencies of around 75% in only a small subgroup of the latter. Most other markers known to date show lower figures and/or can be detected at high frequency in only a subgroup of tumours, for example PSA in prostate cancer. So Trop-2 really stands out."

"It is also a unique marker of cancer metastases in different tumour types -- including colon, stomach, breast, and ovary in man -- and across a number of species," he says. In man, most metastases in lymph nodes or down-stream organs, for example liver in colon cancer, express higher levels of Trop-2 compared with the primary tumours. Trop-2 induces these metastases through mechanisms that the scientists are beginning to unravel.

The most intriguing of these findings, they say, is the presence of two sequence elements in the Trop-2 cytoplasmic tail, the signalling engine of Trop-2, which act as, respectively, an enhancer and a silencer of metastatic propensity. This may be the key to the identification of signalling molecules that promote or inhibit the formation of metastases.

"If we can identify such molecules we will be approaching a situation where we could influence their activity and hence either encourage or prevent it," says Professor Alberti. "This could be an important step towards stopping cancer in its tracks."

In addition, the scientists want to extend their knowledge of the cell changes induced by receptor activation, or signal transduction pathways, triggered by Trop-2. "This will be crucial for the better understanding of the way in which tumour growth is regulated by the gene, and will also provide additional targets for anti-cancer drugs," says Professor Alberti. "We are very excited about the prospects for therapy which we can see arising from this discovery."


Story Source:

The above story is based on materials provided by European Cancer Conference. Note: Materials may be edited for content and length.


Cite This Page:

European Cancer Conference. "Discovery Of Widespread Tumor Growth Gene Holds Promise For Effective Anti-cancer Treatment." ScienceDaily. ScienceDaily, 25 September 2007. <www.sciencedaily.com/releases/2007/09/070924123027.htm>.
European Cancer Conference. (2007, September 25). Discovery Of Widespread Tumor Growth Gene Holds Promise For Effective Anti-cancer Treatment. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2007/09/070924123027.htm
European Cancer Conference. "Discovery Of Widespread Tumor Growth Gene Holds Promise For Effective Anti-cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/2007/09/070924123027.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins